Puma Biotechnology, Inc. (PBYI) — 8-K Filings

8-K Filings (10)

• Puma Biotechnology Changes Fiscal Year End — Jun 24, 2025 Risk: low
  Puma Biotechnology, Inc. filed an 8-K on June 24, 2025, reporting a change in its fiscal year end to December 31st. This change was effective as of June 19, 202
• Puma Biotechnology Files 8-K on Shareholder Vote Matters — Jun 13, 2025 Risk: low
  Puma Biotechnology, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of its security holders on June 11, 2025. The filing details th
• Puma Biotech Announces Director, Officer, and Compensation Changes — May 9, 2025 Risk: medium
  Puma Biotechnology, Inc. announced on May 8, 2025, changes related to its board of directors and executive compensation. Specifically, the company elected new d
• Puma Biotechnology to be Acquired for $1.4 Billion — Sep 16, 2024 Risk: medium
  Puma Biotechnology, Inc. announced on September 12, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of New Horizon Health L
• Puma Biotechnology Prices $180M Stock Offering — Aug 15, 2024 Risk: medium
  On August 14, 2024, Puma Biotechnology, Inc. announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a price of $45
• Puma Biotechnology Files 8-K — Aug 7, 2024 Risk: low
  On August 6, 2024, Puma Biotechnology, Inc. filed an 8-K report to disclose other events. The filing does not contain specific details about the nature of these
• Puma Biotech Appoints New CMO, Adds Director — Jun 24, 2024 Risk: low
  Puma Biotechnology, Inc. announced on June 18, 2024, the appointment of Dr. Jeffrey Handwerker as Chief Medical Officer and the election of Ms. Jennifer Simpson
• Puma Biotechnology Files 8-K Report — May 17, 2024 Risk: low
  On May 17, 2024, Puma Biotechnology, Inc. filed an 8-K report to disclose other events. The filing does not contain specific details regarding new agreements, m
• Puma Biotechnology Files 8-K — Mar 19, 2024 Risk: low
  Puma Biotechnology, Inc. filed an 8-K on March 19, 2024, reporting an event that occurred on March 18, 2024. The filing indicates 'Other Events' as the item inf
• Puma Biotech Files 8-K, Confirms Nasdaq Listing — Jan 18, 2024
  Puma Biotechnology, Inc. filed an 8-K on January 18, 2024, primarily to disclose general information and confirm its registration on The Nasdaq Stock Market LLC

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX